Canada Pharmacy Association Allows Morning After Pill Sales on Shelves
Ottawa, Canada (LifeNews.com) -- The national pharmacy organization in Canada has approved a request to sell the morning after pill "in front of the counter." That means the Plan B drug will be sold on store shelves instead of keeping it behind the pharmacy counter and purchasing the drug through the pharmacist. Once the approval becomes official, Canada will become the fifth country to make the morning after pill as readily available as cough syrup or aspirin. The National Association of Pharmacy Regulatory Authorities has accepted a recommendation from the National Drug Scheduling Advisory Committee, which suggested the change after hearing from the drug's Canadian manufacturer, Paladin Labs Inc. Though the agency approved the request, each of the provincial pharmacy associations oversee the regulations in their parts of the nation, so additional decisions will be needed before the drug is made available in front of the counter nationwide. It could be months before those decisions are made and implemented. Once they approve the NAPRA decision, Canada will join Norway, the Netherlands, Sweden and India in putting the morning after pill on the same level as pre-packaged non-prescription medications. Ref. http://www.lifenews.com/int747.html Read More Comments
Pictures
Activism / Political Updates:
Ottawa, Canada (LifeNews.com) -- The national pharmacy organization in Canada has approved a request to sell the morning after pill "in front of the counter." That means the Plan B drug will be sold on store shelves instead of keeping it behind the pharmacy counter and purchasing the drug through the pharmacist. Once the approval becomes official, Canada will become the fifth country to make the morning after pill as readily available as cough syrup or aspirin. The National Association of Pharmacy Regulatory Authorities has accepted a recommendation from the National Drug Scheduling Advisory Committee, which suggested the change after hearing from the drug's Canadian manufacturer, Paladin Labs Inc. Though the agency approved the request, each of the provincial pharmacy associations oversee the regulations in their parts of the nation, so additional decisions will be needed before the drug is made available in front of the counter nationwide. It could be months before those decisions are made and implemented. Once they approve the NAPRA decision, Canada will join Norway, the Netherlands, Sweden and India in putting the morning after pill on the same level as pre-packaged non-prescription medications.
